StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV)

StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued to investors on Sunday. The firm issued a hold rating on the stock.

ObsEva Price Performance

Shares of OBSV opened at $0.01 on Friday. ObsEva has a one year low of $0.08 and a one year high of $2.14. The firm has a market capitalization of $389,855.00, a PE ratio of -0.01 and a beta of 0.68. The company has a 50-day simple moving average of $0.02 and a two-hundred day simple moving average of $0.04.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.